Literature DB >> 14345318

[ADDITIONAL EXPERIMENTAL STUDIES ON L-DOPA IN PARKINSON'S SYNDROME AND RESERPINE PARKINSONISM].

W BIRKMAYER, O HORNYKIEWICZ.   

Abstract

Entities:  

Keywords:  BRAIN; CATECHOLAMINES; CLINICAL RESEARCH; DOPA; METABOLISM; PARKINSONISM; PHARMACOLOGY; RESERPINE; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14345318     DOI： 10.1007/bf00341704

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr        ISSN： 0003-9373


× No keyword cloud information.
  22 in total

1.  [HEAT REGULATION IN POSTENCEPHALITIC PARKINSONISM].

Authors:  W BIRKMAYER; E NEUMAYER
Journal:  Nervenarzt       Date:  1963-08       Impact factor: 1.214

2.  [EXPERIENCES WITH L-DOPA IN THE THERAPY OF PARKINSONISM].

Authors:  F GERSTENBRAND; K PATEISKY; P PROSENZ
Journal:  Psychiatr Neurol (Basel)       Date:  1963

3.  A BIOCHEMICAL GLIA ERROR IN THE PARKINSON DISEASE.

Authors:  G GOMIRATO; H HYDEN
Journal:  Brain       Date:  1963-12       Impact factor: 13.501

4.  A NEW CONCEPT OF TEMPERATURE REGULATION BY AMINES IN THE HYPOTHALAMUS.

Authors:  W FELDBERG; R D MYERS
Journal:  Nature       Date:  1963-12-28       Impact factor: 49.962

5.  [On the effects of I-DOPA on motor disorders in Parkinson's syndrome. An electromyographic study].

Authors:  G GERSTENBRAND; K PATEISKY
Journal:  Wien Z Nervenheilkd Grenzgeb       Date:  1962

6.  Dopamine metabolism in Parkinson's disease.

Authors:  M GREER; C M WILLIAMS
Journal:  Neurology       Date:  1963-01       Impact factor: 9.910

7.  The occurrence, distribution and physiological role of catecholamines in the nervous system.

Authors:  A CARLSSON
Journal:  Pharmacol Rev       Date:  1959-06       Impact factor: 25.468

8.  The decarboxylation of amino acids related to tyrosine and their awakening action in reserpine-treated mice.

Authors:  H BLASCHKO; T L CHRUSCIEL
Journal:  J Physiol       Date:  1960-05       Impact factor: 5.182

9.  [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Wien Klin Wochenschr       Date:  1961-11-10       Impact factor: 1.704

10.  [Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].

Authors:  H BERNHEIMER; W BIRKMAYER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1961-10-15
View more
  24 in total

Review 1.  Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs.

Authors:  Delphine Charvin; Rossella Medori; Robert A Hauser; Olivier Rascol
Journal:  Nat Rev Drug Discov       Date:  2018-09-28       Impact factor: 84.694

2.  Depression by antiparkinson drugs of reserpine rigidity.

Authors:  I Jurna
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968-05-07

3.  The antagonism between reserpine and some antiparkinson drugs in electroseizure.

Authors:  I Jurna; B Regélhy
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

4.  [Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes)].

Authors:  W Birkmayer; M Mentasti
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1967-08-08

5.  [Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].

Authors:  W Gehlen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974-04-09

6.  [The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. I. Alterations of cerebrospinal fluid in patients with parkinson's disease and normals].

Authors:  E Gründig; F Gerstenbrand; J Bruck; H Gnad; P Prosenz; R Teuflmayr
Journal:  Dtsch Z Nervenheilkd       Date:  1969

7.  [The effects of dopa on inhibited depressions].

Authors:  N Matussek; H Pohlmeier; E Rüther
Journal:  Klin Wochenschr       Date:  1966-06-15

8.  Blood pressure responses to noradrenaline and dopamine infusions in Parkinson's disease and the Shy-Drager syndrome.

Authors:  C S Wilcox; M J Aminoff
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

9.  Neurochemical bases of tremor and other disorders of movement.

Authors:  T L Sourkes; L J Poirier
Journal:  Can Med Assoc J       Date:  1966-01-08       Impact factor: 8.262

10.  [The effects of desmethylimipramine (Pertofran) on catecholamine metabolism in the central nervous system and the Parkinson syndrome].

Authors:  N Matussek; H Pohlmeier
Journal:  Klin Wochenschr       Date:  1965-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.